The Biologics and Vaccines CDMO partner of choice.
The Complete Clinical Journey
We can take you from development through commercialization.
As a partner we will support your programs in Preclinical Phase. Our services include Clone Selection, proof of Concept Studies and more.Read More
As a partner we will support your Early Phase Programs. Our services include Process and Analytical Development, Stability, and more.Read More
As a partner we will support your Late Phase Trials. Our services include FMEA- Risk Assessment, Process Validation, and more.Read More
Setting Ourselves Apart for You
What makes us unique?
A commitment to excellence and success in knowing our customers, their needs and the science required to take their project forward.Learn More
Information & Resources
pAVEwayTM expression system for the efficient expression of therapeutic proteins
The Escherichia coli pAVEwayTM expression system described here has been developed to ensure high product titres and efficient scale up to GMP manufacture, whilst minimizing many common issues seen in other expression systems, such as ‘leaky’ expression (expression of recombinant protein in the absence of inducer).Download
Site Specific PEGylation at Histidine Tags
John Liddell, Ian Hodgson and Charles Heise are co-authors of this paper, in conjuntion with PolyTherics Limited, and UCL School of Pharmacy. The article, which describes the covalent conjustation of PEG site-specifically to a polyhistidine tag (His-tag) on a protein, can be viewed online on Bioconjugate Chemistry.Download
The FDA Provided Guidance for Quality Agreements
This guidance describes our current thinking on defining, establishing, and documenting the responsibilities of each party (or all parties) involved in the contract manufacturing of drugs subject to Current Good Manufacturing Practice (cGMP).Learn More